Tag Archive | "specialty pharma"

Merger & acquisition of Gentium for $1 billion

Tags: , , ,


Merger & acquisition of specialty pharma, Gentium by Jazz Pharmaceuticals for $1 billion. Read the full story

Specialty Pharmaceuticals, Mylan, buys SEZ plant from Unichem for $26.27 million

Tags: , , ,


Unichem Laboratories is selling its Indore-based SEZ plant to generic and specialty pharmaceuticals maker Mylan Laboratories for Rs 161 crore ($26.27 million), as per a stock market disclosure.

Read the full story

Meda in M&A deals for $200 million acquisition of Acton Pharmaceuticals

Tags: , , ,


Acton Pharmaceuticals has entered into definitive M&A deals under which the Company will be acquired by Meda in an all cash transaction. Read the full story

Akorn in $640 million M&A deals for acquisition of Hi-Tech Pharmacal

Tags: , , ,


Akorn and Hi-Tech Pharmacal announced that they have entered into definitive M&A deals under which Akorn will acquire Hi-Tech for $640 million in cash. Read the full story

Dealtalk: TPG explores $3 billion sale of specialty drugmaker Aptalis

Tags: , ,


TPG Capital LP has been exploring a sale of Aptalis Pharma, a specialty drugmaker it has owned since 2008 and values at more than $3 billion, according to dealtalk. Read the full story

Genentech pharma deals Biologics for Tarceva distribution

Tags: , , ,


Biologics pharma deals Genentech to be part of a limited group of specialty pharmacies authorized to distribute Tarceva. Read the full story

Paladin agrees $30 million debt re-financing & licensing agreement with Bioniche

Tags: , ,


Bioniche announced a comprehensive strategic collaboration to refinance and increase Bioniche's debt in a financing and licensing deal Read the full story

Good Start Genetics pharma deals for $28 million loan financing

Tags: , ,


Good Start GeneticsĀ has closed a pharma deals non-dilutive loan facility for up to $28 million of financing from Capital Royalty. Read the full story

Partnering deals the answer for Elan?

Tags: , , , ,


Elan Pharmaceuticals seeking partnering deals following restructuring of its Tysabri deal with Biogen Idec Read the full story

Lundbeck & Recordati announce pharma partnering

Tags: , , , ,


Recordati announces successful pharma partnering alliance, concluding the acquisition of all rights concerning a portfolio of products indicated for the treatment of rare and other diseases and marketed mainly in the United States of America, from Lundbeck, a big pharma company. Read the full story